Article
EIF2S2 as a Prognostic Marker and Therapeutic Target in Glioblastoma: Insights into its Role and Downstream Mechanisms
2024-10-28
Abstract excerpt
<title>Abstract</title> <p>Glioblastoma (GBM) the most common and most aggressive primary brain tumor has a five-year survival rate of less than 5%. The onset of GBM is very complicated and has always been the focus of researchers. This study analyzed data from 155 GBM and 5 normal tissues from The Cancer Genome Atlas (TCGA), and patients were categorized into high and low EIF2S2 expression groups. The Overall su...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 752511fc-9d6c-57fa-bf9d-72c5b6dd19b2
- DOI
- 10.21203/rs.3.rs-5297353/v1
